AccorHotels

Keeping pace with the reiterated timeline

26/04/24 -"Following the return to the CAC40 and investment grade, Accor reported c.8% growth in its Q1 organic revenue and RevPAR, coupled with as-scheduled net unit growth. The mid-term guidance has been ..."

PDF page sample
Pages
52
Language
English
Published on
26/04/24
Download
You may also be interested by these reports :
17/05/24
Following the Q1 releases from Draftkings and Flutter, we are surprised by the extent of BetMGM’s relative underperformance (30-50% growth for the ...
16/05/24
Elior’s H1 results showcased a significant enhancement in profitability, cash generation and deleveraging. The anticipated consolidation synergies, ...
14/05/24
NHH’s Q1 EBITDA margin came in marginally below analysts’ average expectations, despite the above-consensus turnover figure and consensus-aligned ...
13/05/24
We have included the 2023 actual figures and there has been no change at the attributable bottom line level (€118m). The change in our EPS was led by ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO